NCT03487562View on ClinicalTrials.gov

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 8, 2018

Primary Completion Date

January 11, 2019

Study Completion Date

January 11, 2019

Conditions
Healthy
Interventions
DRUG

DWP14012 Amg

DWP14012 Amg

DRUG

DWP14012 Bmg

DWP14012 Bmg

DRUG

Clarithromycin

Clarithromycin 500 mg

DRUG

Amoxicillin

Amoxicillin 1 g

DRUG

Lansoprazole

Lansoprazole 30 mg

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT03487562 - Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects | Biotech Hunter | Biotech Hunter